Eva Teuling
Impact in
Papers in
-
- Genetic Neurodegenerative Diseases 4
- Neuroscience and Neuropharmacology Research 2
- Co-authors
- Casper C. Hoogenraad (6 shared papers)Dick Jaarsma (6 shared papers)Elize D. Haasdijk (5 shared papers)Chris I. De Zeeuw (2 shared papers)Anna Akhmanova (3 shared papers)Jeroen Demmers (1 shared paper)Suaad Ahmed (1 shared paper)Michel O. Steinmetz (1 shared paper)
- Journals
- Journal of Neuroscience (3 papers)Acta Neuropathologica Communications (1 paper)The EMBO Journal (1 paper)Journal of Carcinogenesis (1 paper)Human Molecular Genetics (1 paper)
- Partner nations
- NetherlandsUnited StatesSwitzerland
In The Last Decade
Eva Teuling
14 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 84
- Aging 58
- Neurology 444
- Genetics 238
- Neurology 178
- Cellular and Molecular Neuroscience 274
Countries citing papers authored by Eva Teuling
This map shows the geographic impact of Eva Teuling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Teuling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Teuling more than expected).
Fields of papers citing papers by Eva Teuling
This network shows the impact of papers produced by Eva Teuling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Teuling. The network helps show where Eva Teuling may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Teuling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 196 | |
| 2 | 2008 | 184 | |
| 3 | 2010 | 114 | |
| 4 | 2005 | 106 | |
| 5 | 2010 | 101 | |
| 6 | 2005 | 92 | |
| 7 | 2004 | 89 | |
| 8 | 2008 | 67 | |
| 9 | 2013 | 53 | |
| 10 | 2014 | 48 | |
| 11 | 2011 | 44 | |
| 12 | 2011 | 17 | |
| 13 | 2005 | 3 | |
| 14 | 2010 | 1 |
About Eva Teuling
Eva Teuling is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology, Neurology, Genetics and Neurology, having authored 14 papers that have together received 1.1k indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (5 papers), Parkinson's Disease Mechanisms and Treatments (4 papers), Genetic Neurodegenerative Diseases (4 papers), Neurogenetic and Muscular Disorders Research (4 papers), Neuroscience and Neuropharmacology Research (2 papers), Vestibular and auditory disorders (2 papers), Genetics, Aging, and Longevity in Model Organisms (2 papers) and Inflammatory mediators and NSAID effects (1 paper). The work is most often cited by research in Aging (58 citations), Neurology (444 citations), Genetics (238 citations), Neurology (178 citations) and Cellular and Molecular Neuroscience (274 citations). Eva Teuling has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include Casper C. Hoogenraad, Dick Jaarsma, Elize D. Haasdijk, Chris I. De Zeeuw, Anna Akhmanova, Jeroen Demmers, Suaad Ahmed, Michel O. Steinmetz, Christian Hansel and Claire Piochon. Their work appears in journals such as Journal of Neuroscience, Acta Neuropathologica Communications, The EMBO Journal, Journal of Carcinogenesis and Human Molecular Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.